Source:http://linkedlifedata.com/resource/pubmed/id/19916704
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2009-12-16
|
| pubmed:databankReference | |
| pubmed:abstractText |
To evaluate symptom control and tolerability after abrupt conversion from oral extended-release methylphenidate (ER-MPH) to methylphenidate transdermal system (MTS) via a dose-transition schedule in children with attention-deficit/hyperactivity disorder (ADHD).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
1473-4877
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
26
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
129-37
|
| pubmed:meshHeading |
pubmed-meshheading:19916704-Administration, Oral,
pubmed-meshheading:19916704-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:19916704-Child,
pubmed-meshheading:19916704-Delayed-Action Preparations,
pubmed-meshheading:19916704-Humans,
pubmed-meshheading:19916704-Methylphenidate,
pubmed-meshheading:19916704-Patient Compliance,
pubmed-meshheading:19916704-Prospective Studies
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion.
|
| pubmed:affiliation |
The Ohio State University, Columbus, OH 43074, USA. arnold.6@osu.edu
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|